Search our extensive Laboratory Test Directory to find test codes, ordering recommendations, specimen stability information, Test Fact Sheets, and more.
Recommendations when to order or not order the test. May include related or preferred tests.
Determine in vitro susceptibility to antimicrobial agents for gram-positive rod bacterial organisms.
New York DOH Approval Status
Indicates test has been approved by the New York State Department of Health.
This test is New York state approved.
Specimen Required
Patient PreparationInstructions patient must follow before/during specimen collection.
CollectSpecimen type to collect. May include collection media, tubes, kits, etc.
Actively growing isolate in pure culture.
Specimen PreparationInstructions for specimen prep before/after collection and prior to transport.
Transport sealed container with pure culture on agar slant or in bacterial transport media. Place each specimen in an individually sealed bag.
Storage/Transport TemperaturePreferred temperatures for storage prior to and during shipping to ARUP. See Stability for additional info.
Room temperature. If culture is suspected of being a microorganism identified on the IATA list as an infectious substance affecting humans, submit specimen according to Infectious Substance, Category A, shipping guidelines.
Unacceptable ConditionsCommon conditions under which a specimen will be rejected.
Mixed cultures or nonviable organisms.
RemarksAdditional specimen collection, transport, or test submission information.
Isolate identification and specimen source required.
StabilityAcceptable times/temperatures for specimens. Times include storage and transport time to ARUP.
Expected turnaround time for a result, beginning when ARUP has received the specimen.
2-5 days
Reference Interval
Normal range/expected value(s) for a specific disease state. May also include abnormal ranges.
Susceptible, intermediate, or resistant
Interpretive Data
May include disease information, patient result explanation, recommendations, or details of testing.
Susceptibility testing is performed by CLSI-approved broth microdilution method using custom-made MIC panels.
Compliance Category
Laboratory Developed Test (LDT)
Note
Additional information related to the test.
The following agents will be tested: cefriaxone, clindamycin, daptomycin, doxycycline, erythromycin, gentamicin, levofloxacin, meropenem, penicillin, rifampin, trimethoprim-sulfamethoxazole, and vancomycin. Selective reporting by organism and source.
An additional processing fee will be billed for all organisms not submitted in pure culture, as indicated in the specimen requirements.
If species identification is not provided, identification will be performed at ARUP. Additional charges apply.
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.